Vecchione Carmine, Brandes Ralf P
Institut für Kardiovaskuläre Physiologie, Klinikum der J.W. Goethe-Universität, Frankfurt am Main, Germany.
Circ Res. 2002 Jul 26;91(2):173-9. doi: 10.1161/01.res.0000028004.76218.b8.
3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) improve endothelial function. We determined whether withdrawal of statin therapy affects endothelium-dependent relaxation in mice and studied the underlying mechanism. Mice were treated with daily injections of cerivastatin (2 mg/kg per day SC), atorvastatin (1 and 10 mg/kg per day SC), or placebo. Vascular reactivity was studied in aortic rings from these mice after 10 days of treatment and after cessation of therapy for several days. Both statins improved endothelium-dependent relaxation to acetylcholine. Compared with control, withdrawal of statin treatment transiently (from day 4 to 7) attenuated endothelium-dependent relaxation. In vessels from animals subjected to atorvastatin withdrawal, the antioxidant tiron restored relaxations. Vascular superoxide anion generation was unaffected by statin therapy but was increased during withdrawal. In mice lacking the gp91phox subunit of the NADPH oxidase, no attenuation of acetylcholine-induced relaxation and no increase in superoxide generation were observed after withdrawal of atorvastatin. In human umbilical vein endothelial cells, statins, which decrease the membrane association of NADPH oxidase-activating Rac-1, increased the activity of this GTPase in whole-cell lysates. Withdrawal of statins induced a translocation of Rac-1 from the cytosol to the membrane and transiently increased NADPH-induced lucigenin chemiluminescence in membrane preparations. Rac-1 inactivation by Clostridium difficile toxin B inhibited the cerivastatin-induced oxygen radical production in human umbilical vein endothelial cells. These observations indicate that the withdrawal of statins induces endothelial dysfunction. The underlying mechanism involves activation of a gp91phox-containing NADPH oxidase by Rac-1 and the subsequent scavenging of endothelium-derived NO by superoxide anions generated from this enzyme.
3-羟基-3-甲基戊二酰辅酶A还原酶抑制剂(他汀类药物)可改善内皮功能。我们确定了停用他汀类药物治疗是否会影响小鼠的内皮依赖性舒张,并研究了其潜在机制。小鼠每日皮下注射西立伐他汀(2毫克/千克/天)、阿托伐他汀(1和10毫克/千克/天)或安慰剂。在治疗10天后以及停药数天后,对这些小鼠的主动脉环进行血管反应性研究。两种他汀类药物均改善了对乙酰胆碱的内皮依赖性舒张。与对照组相比,停用他汀类药物治疗会短暂地(从第4天到第7天)减弱内皮依赖性舒张。在接受阿托伐他汀撤药的动物的血管中,抗氧化剂替诺昔康可恢复舒张。血管超氧阴离子生成不受他汀类药物治疗的影响,但在撤药期间会增加。在缺乏NADPH氧化酶的gp91phox亚基的小鼠中,停用阿托伐他汀后未观察到乙酰胆碱诱导的舒张减弱,也未观察到超氧阴离子生成增加。在人脐静脉内皮细胞中,可降低NADPH氧化酶激活的Rac-1膜结合的他汀类药物,增加了全细胞裂解物中这种GTP酶的活性。停用他汀类药物会导致Rac-1从胞质溶胶易位至细胞膜,并短暂增加膜制剂中NADPH诱导的光泽精化学发光。艰难梭菌毒素B使Rac-1失活可抑制西立伐他汀诱导的人脐静脉内皮细胞中的氧自由基产生。这些观察结果表明,停用他汀类药物会诱导内皮功能障碍。潜在机制涉及Rac-1激活含gp91phox的NADPH氧化酶,以及随后该酶产生的超氧阴离子清除内皮衍生的一氧化氮。